Tone mix
Week by week 52 weeks
Share of Mirum Pharmaceuticals, Inc. Common Stock's 140 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 4, 2025 · tone +100Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Uncovering A 31.51% Potential Upside In The Biotech Sector+120
- Week of Apr 21, 2025 · tone -100Leerink Partnrs Has Pessimistic Outlook of MIRM Q1 Earnings-111
- Week of Mar 23, 2026 · tone +99Mirum Pharmaceuticals' (MIRM) Buy Rating Reiterated at HC Wainwright+94
- Week of Aug 25, 2025 · tone +100Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Rating of "Buy" from Analysts+80
- Week of Aug 10, 2026 · tone +98Mirum Pharmaceuticals (NASDAQ:MIRM) Upgraded at Wall Street Zen+78
- Week of May 12, 2025 · tone +100Cantor Fitzgerald Analysts Raise Earnings Estimates for MIRM+75
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Mirum Pharmaceuticals, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +50 |
| Last 30 sessions | 19 | +47 |
| Last 90 sessions | 37 | +32 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock Now Rated "Moderate Buy" by Wall Street AnalystsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock Now Rated "Moderate Buy" by Wall Street Analysts | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.themarketsdaily.com · 1 outletMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock Rated "Moderate Buy" by Sell-Side BrokeragesPositive
- www.themarketsdaily.com · 1 outletCritical Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) versus United Therapeutics (NASDAQ:UTHR)Neutral
- www.tickerreport.com · 1 outletWeekly Investment Analysts' Ratings Changes for Mirum Pharmaceuticals (MIRM)Neutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock Rated "Moderate Buy" by Sell-Side Brokerages | www.themarketsdaily.com | 1 | Positive |
| Critical Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) versus United Therapeutics (NASDAQ:UTHR) | www.themarketsdaily.com | 1 | Neutral |
| Weekly Investment Analysts' Ratings Changes for Mirum Pharmaceuticals (MIRM) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHC Wainwright Analysts Reduce Earnings Estimates for MIRMNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| HC Wainwright Analysts Reduce Earnings Estimates for MIRM | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
5 headlines, average tone +40: 3 positive, 1 neutral and 1 negative. Showing all 5.
- www.themarketsdaily.com · 1 outletQ3 EPS Forecast for Mirum Pharmaceuticals Reduced by AnalystNegative
- www.rttnews.com · 1 outletMirum Pharmaceuticals Meets Primary Endpoint In Phase 3 LIVMARLI StudyPositive
- www.themarketsdaily.com · 1 outletCitigroup Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) StockPositive
- www.rttnews.com · 1 outletMirum Pharmaceuticals Reports Positive Phase 3 LIVMARLI Results; Plans FDA Filing In 2027Positive
- www.dailypolitical.com · 1 outletEquities Research Analysts' Price Target Changes for October 12th (ALH, AMH, CMI, DKNG, EQPT, MIRM, OSK, PCAR, PENN, PNR)Neutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Q3 EPS Forecast for Mirum Pharmaceuticals Reduced by Analyst | www.themarketsdaily.com | 1 | Negative |
| Mirum Pharmaceuticals Meets Primary Endpoint In Phase 3 LIVMARLI Study | www.rttnews.com | 1 | Positive |
| Citigroup Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock | www.themarketsdaily.com | 1 | Positive |
| Mirum Pharmaceuticals Reports Positive Phase 3 LIVMARLI Results; Plans FDA Filing In 2027 | www.rttnews.com | 1 | Positive |
| Equities Research Analysts' Price Target Changes for October 12th (ALH, AMH, CMI, DKNG, EQPT, MIRM, OSK, PCAR, PENN, PNR) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- seekingalpha.com · 1 outletMirum Pharmaceuticals to report Livmarli trial results Monday (MIRM:NASDAQ)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Mirum Pharmaceuticals to report Livmarli trial results Monday (MIRM:NASDAQ) | seekingalpha.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Mirum Pharmaceuticals, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.